Quantumzyme today collaborated with BEC Chemicals to develop sustainable biotransformation and biocatalysis solution for the pharma industry, the companies said in a joint statement.
According to the statement, the agreement grants both parties access to each other’s knowledge and expertise to develop novel solutions for Active Pharmaceutical Ingredient (API) development. Quantumzyme’s expertise in rapid enzyme discovery, enzyme engineering and pilot validation into early-phase projects complements BEC Chemicals’ experience and track record of over 30 commercial manufacturing chemical reactions run on a multi-ton scale. This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
We are really grateful for your blog post. You will find a lot of approaches after visiting your post. Great work
Your blog is very informative. thanks for Sharing this blog.